Page last updated: 2024-08-16

zopiclone and buspirone

zopiclone has been researched along with buspirone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duncton, MA; Emerling, DE; Kelly, MG; Nguyen, MT; Vincent, F1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Belon, JP; Renaud, A1
Ator, NA; Griffiths, RR1
Spealman, RD1
Chouinard, G; Lefko-Singh, K; Teboul, E1

Reviews

1 review(s) available for zopiclone and buspirone

ArticleYear
Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem.
    Cellular and molecular neurobiology, 1999, Volume: 19, Issue:4

    Topics: Anti-Anxiety Agents; Anxiety; Azabicyclo Compounds; Benzodiazepines; Buspirone; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Hypnotics and Sedatives; Piperazines; Pyridines; Zolpidem

1999

Other Studies

5 other study(ies) available for zopiclone and buspirone

ArticleYear
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
    Bioorganic & medicinal chemistry letters, 2009, Dec-01, Volume: 19, Issue:23

    Topics: Amidohydrolases; Carbamates; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Piperazines; Stereoisomerism; Structure-Activity Relationship

2009
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
[Pharmacology and mechanism of action of anxiolytic agents].
    Soins. Psychiatrie, 1989, Issue:101

    Topics: Anti-Anxiety Agents; Azabicyclo Compounds; Benzodiazepines; Buspirone; Humans; Hypnotics and Sedatives; Piperazines; Receptors, GABA-A

1989
Discriminative stimulus effects of atypical anxiolytics in baboons and rats.
    The Journal of pharmacology and experimental therapeutics, 1986, Volume: 237, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Benzodiazepinones; Buspirone; Discrimination Learning; Flumazenil; Isoxazoles; Lorazepam; Male; Papio; Piperazines; Pyrazoles; Pyridazines; Pyrimidines; Quinolines; Rats; Rats, Inbred Strains; Receptors, GABA-A

1986
Discriminative-stimulus effects of midazolam in squirrel monkeys: comparison with other drugs and antagonism by Ro 15-1788.
    The Journal of pharmacology and experimental therapeutics, 1985, Volume: 235, Issue:2

    Topics: Animals; Azabicyclo Compounds; Barbital; Benzodiazepines; Benzodiazepinones; Buspirone; Caffeine; Chlordiazepoxide; Cinanserin; Clozapine; Conditioning, Operant; Cyproheptadine; Diazepam; Diphenhydramine; Discrimination Learning; Electroshock; Flumazenil; Male; Midazolam; Muscimol; Nordazepam; Pentobarbital; Piperazines; Pyridazines; Pyrimidines; Saimiri; Tripelennamine

1985